What’s New In Cancer Immunotherapy? - Cancer Surgeon in Mangalore

The idea of using immunotherapy to treat cancer and other diseases has been around for more than a century, and cancer has long been treated using immunotherapy medications. But the development of immunotherapy medications into a first-line, standard-of-care therapy for specific malignancies did not start until the introduction of so-called checkpoint inhibitors in 2011. Despite immunotherapy medications' breakthrough nature, difficulties still exist. These medications have been demonstrated to have little or no impact on a significant portion of patients and are not licenced for use in treating all malignancies. In addition, the Cancer Surgeon in Mangalore says some patients may experience major adverse effects from checkpoint inhibitors and CAR T-cell treatment, the most recent kind of immunotherapy. Scientists and medical professionals are looking for innovative strategies to boost the usage of immunotherapy medications and aid in stimulating the immune system to more effective...